BDX
59
3
AEE
51
3
ORCL
49
3
FIS
43
5
NEE
39
9
HRB
40
3
ADT
12
2
KLAC
45
3
XEL
48
11
PEP
33
4
PPL
44
9
WAT
55
11
BXP
39
5
NKE
36
2
MU
42
14
FMC
23
7
VRSN
59
4
CLX
65
2
PFG
27
7
WU
26
2
BDX
59
3
AEE
51
3
ORCL
49
3
FIS
43
5
NEE
39
9
HRB
40
3
ADT
12
2
KLAC
45
3
XEL
48
11
PEP
33
4
PPL
44
9
WAT
55
11
BXP
39
5
NKE
36
2
MU
42
14
FMC
23
7
VRSN
59
4
CLX
65
2
PFG
27
7
WU
26
2
Financhill
Back

LeMaitre Vascular Vs. Perspective Therapeutics Industry Stock Comparison

Buy
58

LMAT
LeMaitre Vascular

Last Price:
$92.19
Seasonality Move:
2.06%
Sell
23

CATX
Perspective Therapeutics

Last Price:
$2.87
Seasonality Move:
41.25%
Buy
58
LeMaitre Vascular (LMAT) is a Buy

Is LeMaitre Vascular a Buy, Sell or Hold?

  • The current LeMaitre Vascular [LMAT] share price is $92.13. The Score for LMAT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • LMAT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $2.85. The Score for CATX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LMAT Stock Price Chart

What is LeMaitre Vascular's stock price today?

  • The LeMaitre Vascular share price today is $92.13
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LMAT is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $2.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

LMAT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.14 Sell
Relative Strength Index (14 RSI): 36.22 Sell
Chaikin Money Flow: 7277 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (95.68 - 106.5) Sell
Bollinger Bands (100): (85.3 - 99.88) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.39 Sell
Relative Strength Index (14 RSI): 19.38 Sell
Chaikin Money Flow: -1073375 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.81 - 5.45) Sell
Bollinger Bands (100): (6.72 - 15.04) Sell

LMAT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 94.95 Sell
20-day SMA: 100.43 Sell
50-day SMA: 97.44 Sell
200-day SMA: 83.75 Buy
8-day EMA: 94.34 Sell
20-day EMA: 97.7 Sell
50-day EMA: 97.16 Sell
200-day EMA: 85.16 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.2 Sell
20-day SMA: 3.62 Sell
50-day SMA: 7.99 Sell
200-day SMA: 12.2 Sell
8-day EMA: 3.18 Sell
20-day EMA: 4.2 Sell
50-day EMA: 6.97 Sell
200-day EMA: 10.01 Sell

LeMaitre Vascular Earnings Growth & LMAT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.61 per share, and an increase next year of $0.22 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

LeMaitre Vascular Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):